标题
Current Trend in Antiviral Therapy for Chronic Hepatitis B
作者
关键词
-
出版物
Viruses-Basel
Volume 14, Issue 2, Pages 434
出版商
MDPI AG
发表日期
2022-02-22
DOI
10.3390/v14020434
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Long-term immune protection against HBV: associated factors and determinants
- (2021) Marianna Mastrodomenico et al. Human Vaccines & Immunotherapeutics
- The times they are a-changing – A refined proposal for finite HBV nucleos(t)ide analog therapy
- (2021) Thomas Berg et al. JOURNAL OF HEPATOLOGY
- Incidences and Determinants of Functional Cure during Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B
- (2021) Yao-Chun Hsu et al. JOURNAL OF INFECTIOUS DISEASES
- Emerging Diagnostic Tools to Decide When to Discontinue Nucleos(t)ide Analogues in Chronic Hepatitis B
- (2020) Margarita Papatheodoridi et al. Cells
- Hepatitis B flare after cessation of nucleos(t)ide analogue therapy in HBeAg‐negative chronic hepatitis B: To retreat or not to retreat
- (2020) Yun‐Fan Liaw HEPATOLOGY
- Hepatocellular carcinoma incidence with tenofovir versus entecavir in chronic hepatitis B: a systematic review and meta-analysis
- (2020) Cheng-Hao Tseng et al. Lancet Gastroenterology & Hepatology
- Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patients
- (2020) Mireia García-López et al. JOURNAL OF HEPATOLOGY
- Off‐therapy precipitous HB sAg decline predicts HB sAg loss after finite entecavir therapy in HB eAg‐negative patients
- (2019) Wen‐Juei Jeng et al. JOURNAL OF VIRAL HEPATITIS
- Limited sustained response after stopping nucleos(t)ide analogues in patients with chronic hepatitis B: results from a randomised controlled trial (Toronto STOP study)
- (2019) Kin Seng Liem et al. GUT
- Finite nucleos(t)ide analog therapy in HBeAg-negative chronic hepatitis B: an emerging paradigm shift
- (2019) Yun-Fan Liaw Hepatology International
- Restoring, releasing or replacing adaptive immunity in chronic hepatitis B
- (2019) Mala K. Maini et al. Nature Reviews Gastroenterology & Hepatology
- Clinical utility of HBV surface antigen quantification in HBV e antigen-negative chronic HBV infection
- (2019) Yun-Fan Liaw Nature Reviews Gastroenterology & Hepatology
- Re‐treatment for severe hepatitis flare in HBeAg‐negative chronic hepatitis B: An appraisal with combined HBsAg/ALT kinetics
- (2019) Rong‐Nan Chien et al. JOURNAL OF VIRAL HEPATITIS
- Medication Nonadherence Increases Hepatocellular Carcinoma, Cirrhotic Complications, and Mortality in Chronic Hepatitis B Patients Treated With Entecavir
- (2018) Jung Woo Shin et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- HBsAg Kinetics in Retreatment Decision for Off-Therapy Hepatitis B Flare in HBeAg-Negative Patients
- (2018) Yun-Fan Liaw et al. GASTROENTEROLOGY
- Significance of definitions of relapse after discontinuation of oral antivirals in HBeAg-negative chronic hepatitis B
- (2018) George V. Papatheodoridis et al. HEPATOLOGY
- Incidence and predictors of hepatitis B surface antigen seroclearance after cessation of nucleos(t)ide analogue therapy in hepatitis B e antigen-negative chronic hepatitis B
- (2018) Wen-Juei Jeng et al. HEPATOLOGY
- Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
- (2018) Norah A. Terrault et al. HEPATOLOGY
- DARING-B: discontinuation of effective entecavir or tenofovir disoproxil fumarate long-term therapy before HBsAg loss in non-cirrhotic HBeAg-negative chronic hepatitis B
- (2018) George V Papatheodoridis et al. ANTIVIRAL THERAPY
- Taiwan consensus statement on the management of chronic hepatitis B
- (2018) Rong-Nan Chien et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- The Incidence of Hepatitis B Surface Antigen Loss Between Hepatitis B E Antigen-Negative Noncirrhotic Patients Who Discontinued or Continued Entecavir Therapy
- (2018) Chien-Hung Chen et al. JOURNAL OF INFECTIOUS DISEASES
- EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
- (2017) Pietro Lampertico et al. JOURNAL OF HEPATOLOGY
- Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients – FINITE study
- (2017) Thomas Berg et al. JOURNAL OF HEPATOLOGY
- Viral and Host Responses After Stopping Long-term Nucleos(t)ide Analogue Therapy in HBeAg-Negative Chronic Hepatitis B
- (2016) Christoph Höner zu Siederdissen et al. JOURNAL OF INFECTIOUS DISEASES
- Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
- (2016) Tung-Hung Su et al. LIVER INTERNATIONAL
- Reduced risk of relapse after long-term nucleos(t)ide analogue consolidation therapy for chronic hepatitis B
- (2015) H. Chi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Entecavir safety and effectiveness in a national cohort of treatment-naïve chronic hepatitis B patients in the US - the ENUMERATE study
- (2015) J. Ahn et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B
- (2015) W. Ray Kim et al. CANCER
- Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
- (2015) S. K. Sarin et al. Hepatology International
- Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infection
- (2015) Kosh Agarwal et al. JOURNAL OF HEPATOLOGY
- Serum HBsAg kinetics and usefulness of interferon-inducible protein 10 serum in HBeAg-negative chronic hepatitis B patients treated with tenofovir disoproxil fumarate
- (2015) G. Papatheodoridis et al. JOURNAL OF VIRAL HEPATITIS
- Seven-Year Efficacy and Safety of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection
- (2014) Maria Buti et al. DIGESTIVE DISEASES AND SCIENCES
- Hepatitis B flares in chronic hepatitis B: Pathogenesis, natural course, and management
- (2014) Ming-Ling Chang et al. JOURNAL OF HEPATOLOGY
- Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients With liver cirrhosis
- (2013) Grace Lai-Hung Wong et al. HEPATOLOGY
- Changes of HBsAg and HBV DNA levels in Chinese chronic hepatitis B patients after 5 years of entecavir treatment
- (2013) Wai-Kay Seto et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Reversal of cirrhosis: An achievable goal of hepatitis B antiviral therapy
- (2013) Yun-Fan Liaw JOURNAL OF HEPATOLOGY
- Changes of HBsAg and interferon-inducible protein 10 serum levels in naive HBeAg-negative chronic hepatitis B patients under 4-year entecavir therapy
- (2013) George Papatheodoridis et al. JOURNAL OF HEPATOLOGY
- Sustained Responses and Loss of HBsAg in HBeAg-Negative Patients With Chronic Hepatitis B Who Stop Long-Term Treatment With Adefovir
- (2012) Stephanos J. Hadziyannis et al. GASTROENTEROLOGY
- Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection
- (2012) Tetsuya Hosaka et al. HEPATOLOGY
- Hepatitis B surface antigen levels: association with 5-year response to peginterferon alfa-2a in hepatitis B e-antigen-negative patients
- (2012) Patrick Marcellin et al. Hepatology International
- Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
- (2012) Yun-Fan Liaw et al. Hepatology International
- Effect of nucleos(t)ide analogue therapy on hepatocarcinogenesis in chronic hepatitis B patients: A propensity score analysis
- (2012) Takashi Kumada et al. JOURNAL OF HEPATOLOGY
- Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: Finite treatment duration unlikely
- (2012) Stéphane Chevaliez et al. JOURNAL OF HEPATOLOGY
- Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
- (2012) Patrick Marcellin et al. LANCET
- Three Years of Continuous Entecavir Therapy in Treatment-Naïve Chronic Hepatitis B Patients: VIRAL Suppression, Viral Resistance and Clinical Safety
- (2011) Man-Fung Yuen et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Prediction of off-treatment response to lamivudine by serum hepatitis B surface antigen quantification in hepatitis B e antigen-negative patients
- (2011) Henry L-Y Chan et al. ANTIVIRAL THERAPY
- Entecavir treatment for chronic hepatitis B: Adaptation is not needed for the majority of naïve patients with a partial virological response
- (2011) Roeland Zoutendijk et al. HEPATOLOGY
- Shorter durations and lower doses of peginterferon alfa-2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or C
- (2011) Y.-F. Liaw et al. HEPATOLOGY
- Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B
- (2010) Ting-Tsung Chang et al. HEPATOLOGY
- Durability of peginterferon alfa-2b treatment at 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B
- (2010) Vincent Wai-Sun Wong et al. HEPATOLOGY
- Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B
- (2010) Ting-Tsung Chang et al. HEPATOLOGY
- Long-term use of entecavir in nucleoside-naïve Japanese patients with chronic hepatitis B infection
- (2010) Osamu Yokosuka et al. JOURNAL OF HEPATOLOGY
- Persistence and adherence to nucleos(t)ide analogue treatment for chronic hepatitis B
- (2010) Watcharasak Chotiyaputta et al. JOURNAL OF HEPATOLOGY
- Antiviral therapy of chronic hepatitis B: Opportunities and challenges in Asia
- (2009) Yun-Fan Liaw JOURNAL OF HEPATOLOGY
- Hepatitis B virus infection
- (2009) Yun-Fan Liaw et al. LANCET
- Sustained HBeAg and HBsAg Loss After Long-term Follow-up of HBeAg-Positive Patients Treated With Peginterferon α-2b
- (2008) Erik H.C.J. Buster et al. GASTROENTEROLOGY
- Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
- (2008) Patrick Marcellin et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started